Cambridge Healthtech Institute gets Golden

FRAMINGHAM (09/24/2003) - Jim Golden, former business development manager at 454 Corp. and current member of the Bio ·IT World Editorial Advisory Board, recently accepted a new position as senior vice president and research director at drug discovery technology analyst firm Cambridge Healthtech Institute (CHI) Insights. According to Golden, his new role is to direct CHI advisors' research of new technologies in drug discovery and development.

Join the newsletter!


Sign up to gain exclusive access to email subscriptions, event invitations, competitions, giveaways, and much more.

Membership is free, and your security and privacy remain protected. View our privacy policy before signing up.

Error: Please check your email address.
Show Comments